2011 ACS Logo-Newest
ACS Members: Submit Your Comments
on FDA Risk Assessment by April 29 

The Draft Joint FDA/Health Canada Quantitative Assessment of the Risk of Listeriosis From Soft-Ripened Cheese Consumption in the U.S. and Canada was released for public comment in February. ACS's Regulatory & Academic Committee has been carefully reviewing the report and developing a detailed response that will be posted to the Federal Register next week.  

 

ACS will share its response once it is posted. In the meantime, we urge all members to submit their own comments to the Federal Register. The risk assessment has the potential to spur significant change within our industry, and it will ultimately impact all ACS members -- whether you make, distribute, sell, or simply love artisan cheese of all styles.

ACS needs to present a strong and unified voice to FDA. To do this, we need your help. Please consider sending your own response to FDA by posting directly to the Federal Register. Need ideas as to what to say? Here are some ideas as to how you might focus your response:  

 

(1) Share your personal concern over the economic impact that any regulatory changes may have on your business.  

 

For example:  

 

For producers: "As a small producer, I worry that any changes in regulation based on this risk assessment could inordinately impact businesses like mine. For example, if I were required to test five lots from each batch I produce, my annual costs could exceed $xxxx." (To estimate impact, multiply $200 -- 5 tests at $40 inclusive -- by the total number of batches you produce annually.)

 

For retailers, distributors, or others: "While I realize this is only a risk assessment, I am concerned that regulations may stem from this report that will have a grave economic impact on small producers. This will make it much more difficult for my business, which depends on a strong population of small cheesemakers, to stay afloat."

 

 (2) Ask FDA to incorporate more specific real-world data into the risk assessment.  

 

For example:

 

"I am an artisan/farmstead/specialty cheesemaker, and I would like to request that this risk assessment incorporate some real-world data from producers like me, rather than merely extrapolating data based on isolated research."

 

"FSMA encourages innovation in safe food production. As such, FDA should consider multiple types of interventions -- particularly those that are widely accepted in other countries, and have been proven effective in actual cheesemaking operations. For example, xxxx". (Include intervention strategies that you (for cheesemakers), or the cheesemakers you work with (for retailers, distributors, and others), might use to reduce the risk of illness, such as thermization, micro-filtration, phage, etc.)

 

Please take a moment to post your comments to the Federal Register by April 29.
If you have any questions about the risk assessment, contact the ACS office at 720-328-2788.

 

Thank you for your support,

 

The American Cheese Society 

  

Stay Connected to ACS

 

Follow us on Facebook, Twitter, or LinkedIn. Get updates from the cheese community, connect with fellow cheesemakers, retailers and enthusiasts, and tell us what's happening in your world.

Find us on Facebook     Follow us on Twitter     View our profile on LinkedIn
American Cheese Society
2696 S. Colorado Blvd, Suite 570
Denver, Colorado 80222-5954